🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long Term Safety of Preoperative Percutaneous Intercostal Cryoneurolysis

Recruitingn/aAges 14 Years - anyAllPapa Giovanni XXIII Hospital
NCT07657845 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Follow up of patients who underwent percutaneous cryoneurolysis for pectus excavatum repair (the Nuss procedure) pain management

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who underwent percutaneous cryoneurolysis. * Patients who underwent surgical correction of pectus excavatum according to the Nuss procedure. * Signed informed consent. Exclusion Criteria: * Refusal to participate in the study * Peripheral nervous system disorders * Age \< 14 years * Failure to attend scheduled follow-up visits
💊

What it tests

  • Self-report Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Questionnaire - Pediatric Quality of Life Inventory (PedsQL™) Questionnaire - Patient Self-Assessment Sensory Scale
📍

Where

1 site
ASST Papa Giovanni XXIII
Bergamo, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy